148 related articles for article (PubMed ID: 25715244)
21. Frequency, timing, and type of prodromal symptoms associated with hereditary angioedema attacks.
Prematta MJ; Kemp JG; Gibbs JG; Mende C; Rhoads C; Craig TJ
Allergy Asthma Proc; 2009; 30(5):506-11. PubMed ID: 19843405
[TBL] [Abstract][Full Text] [Related]
22. Clinical impact of peripheral attacks in hereditary angioedema patients.
Kusuma A; Relan A; Knulst AC; Moldovan D; Zuraw B; Cicardi M; Levy RJ; Nuijens JH; Hack CE
Am J Med; 2012 Sep; 125(9):937.e17-24. PubMed ID: 22748405
[TBL] [Abstract][Full Text] [Related]
23. C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study.
Craig TJ; Bewtra AK; Bahna SL; Hurewitz D; Schneider LC; Levy RJ; Moy JN; Offenberger J; Jacobson KW; Yang WH; Eidelman F; Janss G; Packer FR; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
Allergy; 2011 Dec; 66(12):1604-11. PubMed ID: 21884533
[TBL] [Abstract][Full Text] [Related]
24. Characterization of prodromal symptoms in a large population of patients with hereditary angio-oedema.
Magerl M; Doumoulakis G; Kalkounou I; Weller K; Church MK; Kreuz W; Maurer M
Clin Exp Dermatol; 2014 Apr; 39(3):298-303. PubMed ID: 24635064
[TBL] [Abstract][Full Text] [Related]
25. Clinical Pattern and Acute and Long-term Management of Hereditary Angioedema Due to C1-Esterase Inhibitor Deficiency.
Gómez-Traseira C; Pérez-Fernández E; López-Serrano MC; García-Ara MC; Pedrosa M; López-Trascasa M; Caballero T
J Investig Allergol Clin Immunol; 2015; 25(5):358-64. PubMed ID: 26727765
[TBL] [Abstract][Full Text] [Related]
26. Recombinant human-C1 inhibitor is effective and safe for repeat hereditary angioedema attacks.
Li HH; Moldovan D; Bernstein JA; Reshef A; Porebski G; Stobiecki M; Baker J; Levy R; Relan A; Riedl M
J Allergy Clin Immunol Pract; 2015; 3(3):417-23. PubMed ID: 25680925
[TBL] [Abstract][Full Text] [Related]
27. Response time for ecallantide treatment of acute hereditary angioedema attacks.
Riedl M; Campion M; Horn PT; Pullman WE
Ann Allergy Asthma Immunol; 2010 Dec; 105(6):430-436.e2. PubMed ID: 21130380
[TBL] [Abstract][Full Text] [Related]
28. Clinical manifestations, diagnosis, and treatment of hereditary angioedema: survey data from 94 physicians in Japan.
Ohsawa I; Honda D; Nagamachi S; Hisada A; Shimamoto M; Inoshita H; Mano S; Tomino Y
Ann Allergy Asthma Immunol; 2015 Jun; 114(6):492-8. PubMed ID: 25872948
[TBL] [Abstract][Full Text] [Related]
29. Ecallantide: in acute hereditary angioedema.
Garnock-Jones KP
Drugs; 2010 Jul; 70(11):1423-31. PubMed ID: 20614949
[TBL] [Abstract][Full Text] [Related]
30. Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial.
Riedl MA; Bernstein JA; Li H; Reshef A; Lumry W; Moldovan D; Farkas H; Levy R; Baker J; Hardiman Y; Totoritis MC; Relan A; Cicardi M;
Ann Allergy Asthma Immunol; 2014 Feb; 112(2):163-169.e1. PubMed ID: 24468257
[TBL] [Abstract][Full Text] [Related]
31. Development and content validity testing of a patient-reported outcomes questionnaire for the assessment of hereditary angioedema in observational studies.
Bonner N; Abetz-Webb L; Renault L; Caballero T; Longhurst H; Maurer M; Christiansen S; Zuraw B;
Health Qual Life Outcomes; 2015 Jul; 13():92. PubMed ID: 26129930
[TBL] [Abstract][Full Text] [Related]
32. Management and prevention of hereditary angioedema attacks.
Lumry WR
Am J Manag Care; 2013 Jun; 19(7 Suppl):s111-8. PubMed ID: 23844783
[TBL] [Abstract][Full Text] [Related]
33. Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency.
Rubinstein E; Stolz LE; Sheffer AL; Stevens C; Bousvaros A
BMC Gastroenterol; 2014 Apr; 14():71. PubMed ID: 24712435
[TBL] [Abstract][Full Text] [Related]
34. Open-label, multicenter study of self-administered icatibant for attacks of hereditary angioedema.
Aberer W; Maurer M; Reshef A; Longhurst H; Kivity S; Bygum A; Caballero T; Bloom B; Nair N; Malbrán A
Allergy; 2014 Mar; 69(3):305-14. PubMed ID: 24438203
[TBL] [Abstract][Full Text] [Related]
35. C1-INH concentrate for treatment of acute hereditary angioedema: a pediatric cohort from the I.M.P.A.C.T. studies.
Schneider L; Hurewitz D; Wasserman R; Obtulowicz K; Machnig T; Moldovan D; Reshef A; Craig TJ
Pediatr Allergy Immunol; 2013 Feb; 24(1):54-60. PubMed ID: 23173714
[TBL] [Abstract][Full Text] [Related]
36. Icatibant for Multiple Hereditary Angioedema Attacks across the Controlled and Open-Label Extension Phases of FAST-3.
Lumry WR; Farkas H; Moldovan D; Toubi E; Baptista J; Craig T; Riedl M
Int Arch Allergy Immunol; 2015; 168(1):44-55. PubMed ID: 26556097
[TBL] [Abstract][Full Text] [Related]
37. Hereditary angioedema from the patient's perspective: A follow-up patient survey.
Banerji A; Li Y; Busse P; Riedl MA; Holtzman NS; Li HH; Davis-Lorton M; Bernstein JA; Frank M; Castaldo AJ; Long J; Zuraw B; Lumry W; Christiansen S
Allergy Asthma Proc; 2018 May; 39(3):212-223. PubMed ID: 29669666
[TBL] [Abstract][Full Text] [Related]
38. Assessment of home infusion program for treating nonlaryngeal hereditary angioedema attacks.
Kuhlen J; Guyer A; Morphew T; Tachdjian R; Banerji A
Ann Allergy Asthma Immunol; 2014 May; 112(5):471-2. PubMed ID: 24630437
[No Abstract] [Full Text] [Related]
39. Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study.
Baş M; Greve J; Hoffmann TK; Reshef A; Aberer W; Maurer M; Kivity S; Farkas H; Floccard B; Arcoleo F; Martin L; Sitkauskiene B; Bouillet L; Schmid-Grendelmeier P; Li H; Zanichelli A
Allergy; 2013 Nov; 68(11):1452-9. PubMed ID: 24111645
[TBL] [Abstract][Full Text] [Related]
40. Ecallantide for treatment of acute attacks of hereditary angioedema.
Martello JL; Woytowish MR; Chambers H
Am J Health Syst Pharm; 2012 Apr; 69(8):651-7. PubMed ID: 22472866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
